• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    ESA聯(lián)合鐵劑治療腎性貧血的療效觀察及其對促紅素、亞鐵離子的影響

    2021-08-31 06:06劉大鵬
    中國現(xiàn)代醫(yī)生 2021年20期
    關(guān)鍵詞:腎性貧血

    劉大鵬

    [關(guān)鍵詞] 腎性貧血;ESA;蔗糖鐵;靜脈滴注;促紅素;亞鐵離子

    [中圖分類號] R973.3;R556.3? ? ? ? ? [文獻標識碼] B? ? ? ? ? [文章編號] 1673-9701(2021)20-0040-03

    Observation on the therapeutic efficacy of ESA combined with ferralium on renal anemia and its impacts on erythropoietin and ferrous ion

    LIU Dapeng

    General Ward, General Hospital of Fuxin Mining Bureau of Liaoning Health Industry Group,F(xiàn)uxin? ?123000,China

    [Abstract] Objective To investigate the therapeutic efficacy of erythropoiesis-stimulating agents (ESA) combined with ferralium on renal anemia and its impacts on erythropoietin and ferrous ion levels in patients. Methods A total of 86 patients with renal anemia admitted to our hospital from January 2018 to January 2020 were selected as the research objects and divided into the study group and the control groupaccording to the random number table method,with 43 cases in each group. The study group was treated with ESA combined with iron sucrose intravenous drip, while the control group was treated with single ESA. The clinical efficacy, the hematocrit, hemoglobin, serum ferritin levels, and the incidence of adverse reactions of patients in the two groups were observed. Results The total effective rate of clinical treatment in the study group was 95.35%,which was higher than that of 76.74% in the control group,with statistically significant difference between the two groups (P<0.05). Before treatment, the hematocrit, there was no statistically significant differences of hemoglobin and serum ferritin between the two groups (P>0.05). After treatment, the hematocrit, hemoglobin, and serum ferritin levels of patients in the two groups were significantly higher than those before the treatment, with statistically significant differences(P<0.05). Meanwhile, the hematocrit, hemoglobin and serum ferritin in the study group were higher than those in the control group,with statistically significant differences between the two groups(P<0.05). After treatment,the total incidence of adverse reactions in the study group was 4.65%, which was lower than that of 20.93% in the control group, with statistically significant difference between the two groups(P<0.05). Conclusion The treatment of renal anemia with ESA combined with iron sucrose preparation can effectively improve the clinical symptoms and blood environment, and promote the control of condition in patients.

    [Key words] Renal anemia; Erythropoiesis-stimulating agents; Iron sucrose; Intravenous drip; Erythropoietin; Ferrous ion

    猜你喜歡
    腎性貧血
    左卡尼汀和蔗糖鐵對老年血液透析患者腎性貧血及氧化應(yīng)激的影響
    促紅素聯(lián)合琥珀酸亞鐵治療血透患者腎性貧血的療效分析
    不同種類促紅細胞生成素治療維持性血液透析患者腎性貧血的效果
    促紅素對血透患者腎性貧血的治療效果
    腎衰寧治療腎性貧血療效的臨床探討
    腎性貧血的網(wǎng)織紅細胞參數(shù)分析
    己酮可可堿治療尿毒癥患者難治性貧血的研究
    靜脈注射蔗糖鐵與口服多糖鐵復合物對腎性貧血患者的臨床療效觀察
    左卡尼汀聯(lián)合重組人促紅細胞生成素治療腎性貧血的效果觀察
    资兴市| 平陆县| 柳林县| 古交市| 耿马| 灌云县| 珠海市| 平谷区| 察哈| 永济市| 丘北县| 三江| 曲水县| 定州市| 卓尼县| 曲周县| 涪陵区| 左权县| 郑州市| 酉阳| 河北省| 汾阳市| 海晏县| 合江县| 大同市| 林周县| 易门县| 蒲江县| 桐梓县| 陆河县| 崇仁县| 宣城市| 浪卡子县| 新河县| 大邑县| 大化| 襄垣县| 万宁市| 谷城县| 邳州市| 武威市|